As of 2025-09-18, the EV/EBITDA ratio of Inhibrx Inc (INBX) is -2.45. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. INBX's latest enterprise value is 297.20 mil USD. INBX's TTM EBITDA according to its financial statements is -121.47 mil USD. Dividing these 2 quantities gives us the above INBX EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 11.5x - 14.5x | 13.6x |
| Forward P/E multiples | 16.4x - 34.0x | 19.2x |
| Fair Price | (90.55) - 4,177.37 | 1,125.43 |
| Upside | -441.3% - 15642.9% | 4141.3% |
| Date | EV/EBITDA |
| 2025-09-12 | -2.56 |
| 2025-09-11 | -2.68 |
| 2025-09-10 | -2.58 |
| 2025-09-09 | -2.81 |
| 2025-09-08 | -2.75 |
| 2025-09-05 | -2.64 |
| 2025-09-04 | -2.59 |
| 2025-09-03 | -2.60 |
| 2025-09-02 | -2.58 |
| 2025-08-29 | -2.65 |
| 2025-08-28 | -2.61 |
| 2025-08-27 | -2.55 |
| 2025-08-26 | -2.37 |
| 2025-08-25 | -2.27 |
| 2025-08-22 | -2.26 |
| 2025-08-21 | -2.16 |
| 2025-08-20 | -2.19 |
| 2025-08-19 | -2.02 |
| 2025-08-18 | -2.13 |
| 2025-08-15 | -2.06 |
| 2025-08-14 | -2.14 |
| 2025-08-13 | -2.09 |
| 2025-08-12 | -1.90 |
| 2025-08-11 | -1.83 |
| 2025-08-08 | -1.79 |
| 2025-08-07 | -1.83 |
| 2025-08-06 | -1.78 |
| 2025-08-05 | -1.78 |
| 2025-08-04 | -1.88 |
| 2025-08-01 | -1.86 |
| 2025-07-31 | -1.90 |
| 2025-07-30 | -2.02 |
| 2025-07-29 | -2.18 |
| 2025-07-28 | -2.21 |
| 2025-07-25 | -2.03 |
| 2025-07-24 | -2.03 |
| 2025-07-23 | -2.05 |
| 2025-07-22 | -2.01 |
| 2025-07-21 | -1.92 |
| 2025-07-18 | -2.20 |
| 2025-07-17 | -2.10 |
| 2025-07-16 | -2.10 |
| 2025-07-15 | -2.02 |
| 2025-07-14 | -2.02 |
| 2025-07-11 | -1.88 |
| 2025-07-10 | -1.78 |
| 2025-07-09 | -1.78 |
| 2025-07-08 | -1.66 |
| 2025-07-07 | -1.47 |
| 2025-07-03 | -1.23 |